In contrast to prior studies, which focused primarily on TSLP as a therapeutic target rather than a predictive biomarker, our study provides new insights into TSLP’s potential role in immune resolution and disease trajectory in pediatric asthma. The gene discussed is TSLP; the disease is asthma.